对既往因胸腹主动脉瘤行开窗/分支腔内修复术后发生急性分支闭塞的患者行机械血栓清除术
回顾性分析单中心医师发起的研究性器械豁免试验中2012至2024年因胸腹主动脉瘤行开窗/分支腔内修复(F/BEVAR)后发生急性分支支架血栓形成并接受经皮机械血栓清除术的3例患者(占1.3%),均成功恢复血管通畅,平均透视时间15.5分钟,长期随访7支受累血管均保持通畅,无需肠切除或永久透析。作者认为经皮机械血栓清除术是此类患者可行的治疗方式,可能为最佳治疗选择。
要点
- F/BEVAR术后急性内脏动脉分支支架血栓形成罕见(本组3例,占1.3%),但可导致急性肠系膜缺血或急性肾损伤。
- 3例患者均接受经皮机械血栓清除术,全部成功恢复血管通畅,平均透视时间15.5分钟。
- 所有患者均免于肠切除或永久透析,长期随访7支受累血管均保持通畅。
核心结论
- 经皮机械血栓清除术是F/BEVAR术后分支支架急性血栓形成患者可行的治疗方式,包括就诊时病情危重或多血管受累者。
- 鉴于血流恢复迅速,该技术可能为此类患者的最佳治疗方式。
研究设计与样本
- 回顾性综述,纳入2012至2024年单中心医师发起的研究性器械豁免试验中因胸腹主动脉瘤行F/BEVAR的所有患者,识别长期随访期间出现急性移植物血栓形成并接受经皮机械血栓清除术者,描述其术前病程、院内管理及长期随访。
主要发现
- 共识别3例(1.3%)因分支移植物闭塞导致急性肠系膜缺血或急性肾损伤并接受经皮机械血栓清除术的患者。
- 所有患者就诊时均在服用他汀和抗血小板药物,症状发作至就诊时间为11小时至1周。
- 患者1所有4支内脏动脉分支完全闭塞;患者2腹腔干和肠系膜上动脉(SMA)闭塞;患者3右肾动脉闭塞。
- 所有患者机械血栓清除术后均成功恢复血管通畅,平均透视时间15.5分钟。
- 所有患者均免于肠切除或永久透析,7支受累血管在长期随访中均保持通畅。
临床怎么用
- 作者认为经皮机械血栓清除术可作为F/BEVAR术后分支支架急性血栓形成患者的可行治疗方式,包括病情危重或多血管受累者;作者提出该技术可能为此类患者的最佳治疗方式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute thrombosis of visceral artery branch stents represents a rare but potentially devastating complication among patients who have undergone fenestrated and branched endovascular repair (F/BEVAR) for the treatment of thoracoabdominal aortic aneurysm (TAAA). There is limited data regarding the optimal management strategy in these patients. In this study, we describe the management and outcomes of patients who presented with this complication and were subsequently treated with the use of percutaneous mechanical thrombectomy. METHODS: A retrospective review of all patients enrolled in a single-institution, physician-sponsored investigational device exemption trial for endovascular repair of thoracoabdominal aneurysms (F/BEVAR) from 2012 to 2024 was performed. Patients who presented during the long-term follow-up period with acute graft thrombosis and treated with percutaneous mechanical thrombectomy were identified, and their preoperative course, hospital management, and long-term follow-up are described. RESULTS: 3 patients (1.3%) were identified with acute mesenteric ischemia or acute kidney injury due to branch graft occlusion and were subsequently treated with percutaneous mechanical thrombectomy. All patients were on a statin and an antiplatelet agent at the time of presentation, and the time from symptom onset to presentation was between 11 hr and 1 week. Patient 1 had complete occlusion of all 4 visceral artery branches. Patient 2 had occlusion of the celiac and superior mesenteric arteries (SMA), and patient 3 had occlusion of the right renal artery. All had successful return of vessel patency following mechanical thrombectomy, with an average fluoroscopy time of 15.5 min. All were spared bowel resection or permanent need for dialysis, and in each of the 7 affected vessels, patency was intact on long-term follow-up. CONCLUSION: Percutaneous mechanical thrombectomy represents a viable treatment modality for patients with acute thrombosis of branch stents following F/BEVAR, including those who present in extremis or with multivessel involvement. Given the rapid rate of flow restoration, this technique may represent the optimal treatment modality for this patient population.
引用
- Nelson CR, Saldana-Ruiz N, Nkansah R, et al. Mechanical Thrombectomy for the Management of Acute Branch Occlusions in Patients who Previously Underwent Fenestrated/Branched Endovascular Repair for Thoracoabdominal Aneurysm. Ann Vasc Surg. 2025. PMID: 40154952. doi:10.1016/j.avsg.2025.03.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。